Cargando…

Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma

Endeavors towards identifying key molecular markers for early diagnosis and treatment are driving the clinical study of papillary thyroid carcinoma (PTC). Recent studies have indicated that protein phosphatase, Mg(2+)/Mn(2+) dependent, 1D (PPM1D) exerts an oncogenic function by increasing cell proli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Zhong-Wu, Wen, Duo, Wei, Wen-Jun, Han, Li-Tao, Xiang, Jun, Wang, Yu-Long, Wang, Yu, Liao, Tian, Ji, Qing-Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040886/ https://www.ncbi.nlm.nih.gov/pubmed/31922231 http://dx.doi.org/10.3892/or.2020.7458

Ejemplares similares

PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia
por: Li, Bin, et al.
Publicado: (2020)

Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway
por: Jin, Jun-Qing, et al.
Publicado: (2021)

Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway
por: Liao, Tian, et al.
Publicado: (2016)

PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38
por: Zhang, Min, et al.
Publicado: (2015)

miR-576-5p Promotes the Proliferation of Papillary Thyroid Carcinoma through the MAPK4-AKT Pathway
por: Hai, Rui, et al.
Publicado: (2022)

IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis
por: Lu, Zhong-Wu, et al.
Publicado: (2020)

Silencing UBQLN2 Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma (ESCC) via Activating p38 MAPK
por: Wang, Jia-Lin, et al.
Publicado: (2023)

WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade
por: Huang, Shiu-Wen, et al.
Publicado: (2019)

p38 MAPK in MDS
por: Gañán‐Gómez, Irene, et al.
Publicado: (2015)

LZAP Inhibits p38 MAPK (p38) Phosphorylation and Activity by Facilitating p38 Association with the Wild-Type p53 Induced Phosphatase 1 (WIP1)
por: An, Hanbing, et al.
Publicado: (2011)

PRDM16 Inhibits Cell Proliferation and Migration via Epithelial-to-Mesenchymal Transition by Directly Targeting Pyruvate Carboxylase in Papillary Thyroid Cancer
por: Liu, Wan-Lin, et al.
Publicado: (2021)

YAP1 and P53 Expression in Papillary Thyroid Carcinoma
por: Abdelhafez, Dalia Nabil, et al.
Publicado: (2023)

Cholesterol Perturbation in Mice Results in p53 Degradation and Axonal Pathology through p38 MAPK and Mdm2 Activation
por: Qin, Qingyu, et al.
Publicado: (2010)

Verteporfin inhibits papillary thyroid cancer cells proliferation and cell cycle through ERK1/2 signaling pathway
por: Liao, Tian, et al.
Publicado: (2018)

Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope
por: Perfettini, Jean-Luc, et al.
Publicado: (2005)

Effects of AQP5 gene silencing on proliferation, migration and apoptosis of human glioma cells through regulating EGFR/ERK/ p38 MAPK signaling pathway
por: Yang, Jian, et al.
Publicado: (2017)

PPM1D silencing by RNA interference inhibits the proliferation of lung cancer cells
por: Zhang, Chen, et al.
Publicado: (2014)

Lovastatin‐mediated MCF‐7 cancer cell death involves LKB1‐AMPK‐p38MAPK‐p53‐survivin signalling cascade
por: Huang, Shiu‐Wen, et al.
Publicado: (2019)

UBR5 regulates proliferation and radiosensitivity in human laryngeal carcinoma via the p38/MAPK signaling pathway
por: Wang, Kai, et al.
Publicado: (2020)

Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway
por: He, Dan, et al.
Publicado: (2020)

Feedback inhibition of CREB signaling by p38 MAPK contributes to the negative regulation of steroidogenesis
por: Li, Jiaxin, et al.
Publicado: (2017)

Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas
por: Corapcioglu, Demet, et al.
Publicado: (2006)

CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways
por: Li, Chuang, et al.
Publicado: (2021)

New Insights into the p38γ and p38δ MAPK Pathways
por: Risco, Ana, et al.
Publicado: (2012)

The activation of p38 MAPK limits the abnormal proliferation of vascular smooth muscle cells induced by high sodium concentrations
por: WU, YAN, et al.
Publicado: (2016)

A p38mapk-p53 cascade regulates mesodermal differentiation and neurogenesis of embryonic stem cells
por: Hadjal, Y, et al.
Publicado: (2013)

IL-2 enhanced MHC class I expression in papillary thyroid cancer with Hashimoto's thyroiditis overcomes immune escape in vitro
por: Hu, Jia-Qian, et al.
Publicado: (2020)

Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D
por: Castellino, Robert C., et al.
Publicado: (2007)

Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC
por: Yang, Shize, et al.
Publicado: (2017)

p38γ and p38δ Mitogen Activated Protein Kinases (MAPKs), New Stars in the MAPK Galaxy
por: Escós, Alejandra, et al.
Publicado: (2016)

IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis
por: Han, Li-Tao, et al.
Publicado: (2019)

Roles of p38 MAPK signalling in intervertebral disc degeneration
por: Shi, Zheng‐wei, et al.
Publicado: (2023)

Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer
por: Zhang, Hui-Min, et al.
Publicado: (2022)

Syntenin regulates melanogenesis via the p38 MAPK pathway
por: Sun, Lijun, et al.
Publicado: (2020)

The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy
por: Wang, Shudong, et al.
Publicado: (2016)

p38 MAPK Signaling in Osteoblast Differentiation
por: Rodríguez-Carballo, Eddie, et al.
Publicado: (2016)

p38 MAPK in cardioprotection – are we there yet?
por: Martin, E D, et al.
Publicado: (2015)

P38 MAPK and Radiotherapy: Foes or Friends?
por: García-Flores, Natalia, et al.
Publicado: (2023)

CITED1 promotes proliferation of papillary thyroid cancer cells via the regulation of p21 and p27
por: Li, Hai, et al.
Publicado: (2018)

The IRE1α Arm of UPR Regulates Muscle Cells Immune Characters by Restraining p38 MAPK Activation
por: Gu, RuiCai, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4bipmsp1f9jkcreahpihs3ptan